Written by: Iqbal Elyazar

We live side by side with mosquitoes every day, yet we rarely realize that a malaria attack begins within seconds, often before we even have time to slap our skin.

Defense Line 1: Avoid Mosquito Bites

In fact, we have many ways to protect ourselves from mosquito bites. These include staying indoors at night, installing mosquito screens on doors and windows, sealing gaps where mosquitoes can enter, sleeping under bed nets, using electric fans, or employing mosquito swatters.

The principle is simple: avoid contact with mosquitoes as much as possible, both while we are awake and throughout the night while we sleep.

When we let our guard down, a mosquito can land on the skin and begin its work. From the outside, a mosquito’s mouth appears to be a single slender needle. In reality, it consists of six fine needle‑like structures: some pierce the skin, others locate blood vessels, some inject saliva, and others draw blood.

Mosquito saliva is not ordinary saliva. It contains various active substances, including anticoagulants that prevent blood from clotting, vasodilators that widen small blood vessels, and mild anesthetics that make the bite barely noticeable.

It is through this saliva that malaria parasites, in the form known as sporozoites, enter the human body. This process happens very quickly, often in less than a minute. The number of sporozoites injected may be small, even just one, or it may reach hundreds in a single bite.

Yet even a single sporozoite that successfully reaches the liver is enough to initiate a malaria infection.

Defense Line 2: Prevent Sporozoites from Reaching the Liver

When a mosquito injects sporozoites into the skin, not all of them succeed in entering the body. Some remain in the skin and eventually die. Others, however, manage to find small blood vessels and enter the bloodstream. This is where the danger lies, because sporozoites carried by the bloodstream will travel to the liver, an organ responsible for filtering toxins and converting them into safer substances to be excreted through urine or bile.

For malaria parasites, the liver is their first stronghold. Within less than an hour after a mosquito bite, sporozoites begin invading liver cells (hepatocytes).

At this second defense line, the goal is to prevent sporozoites from successfully entering the liver.

The liver provides a sanctuary where parasites can evade the immune system. In Plasmodium vivax and P. ovale, some parasites can remain dormant in the liver as hypnozoites, which may later reactivate and cause malaria relapses.

Inside the liver, sporozoites multiply into thousands of merozoites, which will eventually enter the bloodstream and invade red blood cells, marking the onset of familiar malaria symptoms. Unfortunately, there is little we can do at this stage. Once the parasite reaches the liver, it becomes a biological battle between the parasite and the immune system.

Research is ongoing to enhance the body’s ability to produce antibodies that can capture sporozoites in the bloodstream before they reach the liver.

Defense Line 3: Destroy Parasites in Liver Cells

After the first two defense lines fail, malaria parasites finally reach their main base: the liver. Each sporozoite that enters the liver infects a single liver cell. Inside that cell, the parasite multiplies rapidly, causing the cell to swell many times its normal size.

A single infected liver cell can produce between 10,000 and 40,000 merozoites, the next wave of parasites.

After about one week, the swollen liver cell ruptures, releasing thousands of merozoites into nearby blood vessels. From there, they enter the bloodstream and spread throughout the body. At this point, the third defense line collapses, and a massive attack on red blood cells begins.

To combat parasites in the liver, we rely on malaria drugs that specifically target this stage: primaquine and tafenoquine. These drugs damage the parasite’s mitochondria, generate molecules that disrupt the parasite’s protective membranes, and damage its DNA, preventing survival within liver cells.

If hypnozoites are not eliminated, they can remain hidden in the liver and reactivate at any time, causing malaria relapse.

Primaquine and tafenoquine kill parasites by generating oxidative molecules. Red blood cells normally have a natural antioxidant “shield” maintained by an enzyme called G6PD.

If a person has sufficient G6PD enzyme, their red blood cells remain protected. However, in individuals with G6PD deficiency, red blood cells are vulnerable and can easily rupture (hemolysis), which can be dangerous.

For this reason, primaquine and tafenoquine must only be given after confirming that the patient has adequate G6PD enzyme levels.

Defense Line 4: Destroy Parasites in the Blood

When malaria parasites (merozoites) are released from the liver into the bloodstream, they begin invading red blood cells. Each merozoite infects one red blood cell, consumes its energy, and then divides into multiple new parasites:

• P. falciparum: 16-32 new merozoites per red blood cell
• P. vivax: 12-24 new merozoites per red blood cell

Once the red blood cell bursts, the new merozoites are released and seek other red blood cells to invade. This cycle repeats:

• every 2 days for P. falciparum, P. vivax, and P. ovale
• every 3 days for P. malariae
• every 1 day for P. knowlesi

If untreated, parasite numbers increase rapidly. In theory, a single sporozoite could give rise to hundreds of millions of merozoites within a week.

In reality, growth is slower because merozoites survive only 1–2 minutes outside red blood cells. If they fail to find a new cell quickly, they die—making this the most vulnerable stage of their life cycle.

The immune system also plays a role. Antibodies and CD4+ T cells help recognize and destroy some merozoites. In individuals previously exposed to malaria, this immune response is usually stronger.

Only 10-20% of P. falciparum merozoites successfully invade the next red blood cell

For P. vivax, the probability is even lower, as it can only infect young red blood cells, which make up less than 1% of all red blood cells

Many parasites, especially P. falciparum, hide by adhering to blood vessel walls, particularly in the liver, spleen, and brain.

Without treatment, infection can persist. P. falciparum infections may last up to six months, while P. vivax infections can persist for years due to dormant hypnozoites in the liver.

The most effective modern malaria treatments are Artemisinin‑based Combination Therapies (ACTs), such as Dihydroartemisinin-Piperaquine (DHA-PPQ). DHA acts rapidly to kill parasites inside infected red blood cells (half‑life ~1 hour). Piperaquine prevents parasites from detoxifying their own waste products, causing toxic buildup and death. Piperaquine remains in the body for a long time (half‑life ~30 days), helping prevent reinfection.

Other drugs, such as mefloquine, act similarly to piperaquine and remain in circulation for about three weeks.

With these drug combinations, we can halt the cycle of red blood cell destruction and prevent further parasite development.

Defense Line 5: Stop Gametocytes from Infecting Mosquitoes

In the bloodstream, some merozoites develop into gametocytes, the forms capable of infecting mosquitoes. A person carrying gametocytes can transmit malaria to mosquitoes.

When a mosquito feeds on such a person, it may become a vector capable of transmitting malaria to others.

In Plasmodium falciparum, gametocytes require about 8 days to mature and can survive for up to 4 weeks. This means that without anti‑gametocyte treatment, a patient may continue to transmit malaria to mosquitoes even after clinical recovery.

In contrast, P. vivax gametocytes form much faster, within 2 days, but survive for only about 1 week.

Interestingly, gametocytes can influence human physiology by releasing chemical signals that make infected individuals more attractive to female mosquitoes.

Once inside the mosquito, gametocytes undergo sexual development and produce sporozoites, which are then ready to be transmitted to the next human host.

Our weapons against gametocytes are primaquine and tafenoquine. These drugs effectively clear gametocytes from the bloodstream, breaking the transmission chain from humans to mosquitoes.

Ultimately, each line of defense represents an opportunity to stop malaria before it spreads further. When we understand how the enemy operates, we know where to stand, how to prepare, and how to fight.